MATEON’S PHASE 2 GLOBAL STUDY FOR OT-101/ TGF-β INHIBITOR AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN ARGENTINA.

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling